Investment News

17h

Eli Lilly Breaks Ground on $6.5 B Houston Life‑Sciences Plant as Morgan Stanley Closes $1.3 B Growth Equity Fund

  • Eli Lilly begins construction on a $6.5 billion pharmaceutical manufacturing facility in Texas, while Morgan Stanley closes its $1.3 billion North Haven Growth & Innovation Fund.
CTA-image

Market Movers (Top 10)
Last Updated:
Market Movers (Bottom 10)
Last Updated: